CClinicalTrials.gg
RecruitingNCT06365944PRECCOCEUpdated Apr 24, 2024

Concussion in French Non-professional Handball League : Efficiency of a Concussion Protocol, the White Card Process

An observational study in Brain Concussion and Cerebral Concussion, sponsored by University Hospital, Bordeaux. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-24.

Sponsored by University Hospital, Bordeaux · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Apr 2024; still recruiting 2 years 5 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
3,000
Ages
18 Years and older
Sex
All
01

Study summary

Sport related concussion is a major issue for many contact sports, such as Rugby, Football, Hockey and Handball. As a response, some federations like World Rugby set up a concussion protocol, that starts with the referee having the responsibility to issue a blue card when suspecting a concussed player and thus have him off the field for medical examination. The French handball federation (FFHB) as well as its concussion protocol called "Protocole carton blanc", in this study we aim to describe the efficiency of this protocol.

Read the detailed description

Sport related concussion is a major issue for many contact sports, such as Rugby, Football, Hockey and Handball. The short, medium and long-term issues of such impact are still debated but some studies have pointed the fact that acute concussion, repetitive concussions, and even "sub-concussive" impacts could major the risk of developing brain diseases and cognitive impairments. As a response, some federations like World Rugby set up a concussion protocol, that starts with the referee having the responsibility to issue a blue card when suspecting a concussed player and thus have him off the field for medical examination. The French handball federation (FFHB) as well as its concussion protocol called "Protocole carton blanc", in this study we aim to describe the efficiency of this protocol.

This study will be an epidemiological descriptive and prospective study with a brief questionnaire sent off to any player, above 18 years old, male or female, that had receive a white card during an official match in the French amateur Handball league along two regular season. The results will bring details on how concussion occurs on field and how this protocol is efficient to bring the player to consult a health professional.

02

Conditions studied

  • Brain Concussion
  • Cerebral Concussion

Browse trials for

Keywords

  • Sport-related Concussion
  • Handball
  • Epidemiology
03

In context

Brain Concussion

530 studies on the registry are indexed under Brain Concussion; 151 are open to participants now.

This study's planned enrollment of 3,000 is above the median of 180 across 146 observational studies indexed under Brain Concussion.

Browse Brain Concussion studies →

Lead sponsor

University Hospital, Bordeaux is the lead sponsor of 783 studies on the registry; 188 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This study is descriptive, prospective, with a questionnaire sent off to any player, above 18 years old, male or female, that had receive a white card during an official match in the French amateur Handball league along two regular season.During an official game, if the referee issues a white card, the player is then contacted by the French Handball Federation (FFHB) via an email in a day.

Inclusion criteria

  • Male or female
  • Over 18 years old
  • Who had received a white card during an official game
  • having an email address registered in the FFHB register

Exclusion criteria

Exclusion Criteria:

  • Any refusal to participate
  • Inability to respond
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
3,000 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Proportion, as a percentage, of participant declaring no medical care while being estimated at risk of having a concussion (assessed by answers to the questionnaire)

    Risk of concussion estimated by questionnaire collecting the following informations : - Sport Concussion Assessment Tool 6 (SCAT6)'s 22 symptoms, each symptoms is scales from 0 to 6, 6 being the highest intensity of the symptom. Having \> 1 in at least two different symptoms is considered at risk of having a concussion

    Time frame: Day 0

07

Study locations

1 of 1 sites recruiting
  • Bordeaux University Hospital
    Bordeaux, France
    • Quentin LHUAIRE · Contact
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06365944
Lead sponsor
University Hospital, Bordeaux
Responsible party
Sponsor
First posted
Apr 15, 2024
Start date
Apr 20, 2024
Primary completion
Apr 20, 2026 (estimated)
Completion
Apr 20, 2026 (estimated)
Last update
Apr 24, 2024

Study contacts

Quentin LHUAIRE
Contact
quentin.lhuaire@u-bordeaux.fr
05 56 79 55 46 ext. +33
Helene CASSOUDESALLE, MD
Contact
helene.cassoudesalle@chu-bordeaux.fr
05 56 79 55 46 ext. +33
Helene CASSOUDESALLE
principal investigator · University Hospital, Bordeaux

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion